Lenvima 24 mg

LENVIMA 24 MG capsules contain Lenvatinib Mesylate, used for targeted therapy in cancer treatment. This oral medication is manufactured by Eisai Limited in Canada.

LENVIMA 24 MG capsules are primarily used in the treatment of certain types of cancer. Lenvatinib Mesylate, the active ingredient, is a tyrosine kinase inhibitor that targets specific proteins involved in cancer cell growth. This medication is often prescribed for advanced or metastatic cancers, where it helps to slow down the progression of the disease. Patients may wonder, 'What is Lenvatinib used for?' and the answer lies in its role as a targeted therapy for cancer treatment.

Common effects of LENVIMA 24 MG capsules may include fatigue, hypertension, diarrhea, and decreased appetite. Some patients might experience nausea, vomiting, or weight loss. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider. The medication works by inhibiting specific proteins that contribute to cancer cell growth, which can lead to these side effects.

LENVIMA 24 MG capsules should be handled with care and stored as directed. It's important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their doctor before using this medication.

LENVIMA 24 MG capsules may interact with other medications, including those that affect liver enzymes. It's crucial to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication. Always consult a healthcare professional for personalized advice.